An RNA-only CRISPR-Cas9-Based Therapy to Eliminate Latent Infection of HIV

Xu Tan of Tsinghua University in China will harness the genome-editing power of the CRISPR-Cas9 system to eliminate latent HIV infection and provide a proof-of-concept for a potential cure for HIV infection.